According to J.P. Morgan, Genpact G price target is raised to $19.
J.P. Morgan said that 3Q11 results came in ahead of expectations and G expectedly increased its revenue guidance. “We retain our Neutral rating on G given a relatively defensive nature of its growth rate, but potential upside to be limited by premium valuation (G trades at 21x our CY12 estimates vs. peers at 16x).”
Genpact closed on Friday at $17.04.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in